Beranda › Kanker Tiroid › California
Uji klinis Kanker Tiroid di California
14 studi untuk Kanker Tiroid mencari peserta di lokasi di California.
Kota di California
Teks studi resmi (Bahasa Inggris)
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Mission Hope Medical Oncology - Arroyo Grande, Arroyo Grande
- PCR Oncology, Arroyo Grande
- AIS Cancer Center at San Joaquin Community Hospital, Bakersfield
- dan 20 lainnya
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 40 hingga 75 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT05334069DESTINY-PANTUMOUR04
- Research Site, San Diego
Menerima pesertaStudi observasional
Usia 18 hingga 130 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07124000Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
- The Angeles clinic - A cedars SINAI AFFILIATE, Los Angeles
- USC Norris Comprehensive Cancer Center, Los Angeles
- University of California, San Francisco (UCSF), San Francisco
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT05786924Selpercatinib Pre-RAI in Patients With RET Fusion Thyroid Cancer (RAISE)
- The Unviersity of California, San Francisco (UCSF), San Francisco
Menerima pesertaFase 2
Usia 2 hingga 25 · Semua jenis kelamin · Diperbarui 24 Jul 2026 · NCT06458036Navigation Intervention for Adolescent and Young Adult Cancer Survivors
- KP Southern California - Department of Research & Evaluation, Pasadena
Menerima peserta
Usia 21 hingga 45 · Semua jenis kelamin · Diperbarui 6 Jul 2026 · NCT07406087Comparison of I-124 PET/CT for the Diagnosis of Thyroid Cancer
- University of California, San Francisco, San Francisco
Menerima pesertaFase 2
Usia 13 ke atas · Semua jenis kelamin · Diperbarui 18 Jun 2026 · NCT06961084A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
- St Joseph Heritage Healthcare, Santa Rosa
Menerima pesertaFase 1/2
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 27 Mei 2026 · NCT03093116Active Surveillance of Papillary Thyroid Microcarcinoma
- Cedars-Sinai Medical Center, Los Angeles
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 7 Mei 2026 · NCT02609685Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
- City of Hope, Duarte
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
- Stanford Cancer Institute, Stanford
Menerima pesertaFase 1
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 17 Mar 2026 · NCT04119024Development of Liquid Biopsy Technologies for Noninvasive Cancer Diagnostics in Patients With Suspicious Thyroid Nodules or Thyroid Cancer
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 10 Mar 2026 · NCT04742608Evaluation of DNA Methylation Signatures for the Diagnosis and Management of Thyroid Nodules
- City of Hope Medical Center, Duarte
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Feb 2026 · NCT05229341cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
- City of Hope, Duarte
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 40 ke atas · Semua jenis kelamin · Diperbarui 20 Jan 2026 · NCT05366881Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer
- University of California, San Francisco, San Francisco
Menerima pesertaFase 2
Usia 2 hingga 99 · Semua jenis kelamin · Diperbarui 14 Nov 2025 · NCT05783323APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
- Cedars-Sinai Medical Center - Samuel Oschin Comprehensive Cancer Institute, Los Angeles
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 27 Jun 2025 · NCT03175224Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.